Oruka Therapeutics, Inc. — insider transactions

8 transactions on record · ORKA · CIK 907654

Aggregates

computed from the filings below
Purchases, 12m
0
count of open-market buys
Sales, 12m
8
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
1
Bought, 3m
$0
Sold, 3m
$1M
Median disclosure lag
0.0 d
trade date to filing date
Largest single trade, 24m
$480.2K
2026-07-13
Director share, 12m
0.0%
of transactions where role is stated
Current run
8 sells
consecutive same-direction transactions
Net 3m flow
-$1M
purchases minus sales
Total on record
8

Transactions

8 most recent shown
DisclosedTradedLag, dInsiderRoleTransactionSharesPriceValueSource
2026-07-132026-07-130Agarwal ArjunSenior Vice President, FinanceExercise of derivative1,458$34.39$50.1Kfiling
2026-07-132026-07-130Agarwal ArjunSenior Vice President, FinanceOpen market sale5,656$84.90$480.2Kfiling
2026-07-132026-07-130Agarwal ArjunSenior Vice President, FinanceExercise of derivative1,458$0.00filing
2026-07-132026-07-130Agarwal ArjunSenior Vice President, FinanceExercise of derivative8,541$12.50$106.8Kfiling
2026-07-132026-07-130Agarwal ArjunSenior Vice President, FinanceOpen market sale3,743$84.26$315.4Kfiling
2026-07-132026-07-130Agarwal ArjunSenior Vice President, FinanceExercise of derivative8,541$0.00filing
2026-07-132026-07-130Agarwal ArjunSenior Vice President, FinanceOpen market sale300$83.07$24.9Kfiling
2026-07-132026-07-130Agarwal ArjunSenior Vice President, FinanceOpen market sale300$85.63$25.7Kfiling

Source: U.S. Securities and Exchange Commission, EDGAR

Oruka Therapeutics, Inc. insider transactions — 8 filings on record — Tapewire